OBI-992, a novel TROP2 targeting antibody-drug conjugate, displayed excellent antitumor efficacy in various animal models

被引：0
|
作者：
Li, Wan-Fen
Chiang, Ming-Feng
Weng, Hao-Cheng
Yang, Jhih-Jie
Wu, Hsin-Shan
Lin, Chun-Jung
Chiu, Ping-Tzu
Lai, Ming-Tain
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1893
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1893
引用
收藏
页数：2
相关论文
共 50 条
  • [31] An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer
    Jacob, Joan
    Francisco, Liezl E.
    Chatterjee, Treena
    Liang, Zhengdong
    Subramanian, Shraddha
    Liu, Qingyun J.
    Rowe, Julie H.
    Carmon, Kendra S.
    BRITISH JOURNAL OF CANCER, 2023, 128 (08) : 1592 - 1602
  • [32] Development of a novel antibody-drug conjugate targeting endosialin/TEM-1: potent antitumor activity in sarcoma
    Sala, Gianluca
    Iacobelli, Stefano
    Capone, Emily
    PIccolo, Enza
    Sauniere, Jean-Fred
    Douet, Vanessa Vannucci
    CANCER RESEARCH, 2017, 77
  • [33] Results from a phase Ia/Ib Study of ESG401, a novel Trop2 antibody-drug conjugate, in patients with different subtypes of metastatic breast cancer
    Ma, F.
    Qiu, F.
    Tong, Z.
    Wang, J.
    Shi, Y.
    Zhang, Y.
    Yu, G.
    Shi, H.
    Wu, X.
    Liu, A.
    Zhang, Y.
    Wang, H.
    Cheng, Y.
    Yang, H.
    Li, H.
    Chang, J.
    Xing, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S361 - S362
  • [34] Phase 1a study of ESG401, a Trop2 antibody-drug conjugate, in patients with locally advanced/metastatic solid tumors
    Wang, Jiani
    Tong, Zhongsheng
    Tan, Yinuo
    Shi, Yehui
    Wu, Yun
    Zhou, Qing
    Xing, Xiaoyan
    Chen, Xiaomei
    Qiu, Fuming
    Ma, Fei
    CELL REPORTS MEDICINE, 2024, 5 (09)
  • [35] A Novel Antibody-Drug Conjugate Targeting Nectin-2 Suppresses Ovarian Cancer Progression in Mouse Xenograft Models
    Sim, Yun Hee
    Um, Yun Jung
    Park, Jeong-Yang
    Seo, Min-Duk
    Park, Sang Gyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [36] Novel CDH17-targeting antibody-drug conjugate exhibits anti-tumor efficacy in preclinical models of gastrointestinal cancers
    Wong, Po Yee
    He, Lin
    Chow, Kronos
    Wong, Kwan Wa
    O, Chui Yee
    Wong, Dennis
    Luk, John Moon
    Lo, Pui-Chi
    Wong, Kwong Fai
    CANCER RESEARCH, 2024, 84 (06)
  • [37] A novel antibody-drug conjugate directed to the ALK receptor tyrosine kinase demonstrates efficacy in models of neuroblastoma
    Sano, Renata
    Krytska, Kateryna
    Larmour, Colleen
    Ligon, Gwenda F.
    Lillquist, Jay S.
    Cucchi, Ulisse
    Orsini, Paolo
    Rizzi, Simona
    McMahon, Gerald
    Alvarado, Diego
    Mosse, Yael P.
    CANCER RESEARCH, 2016, 76
  • [38] Antibody-drug conjugate MORAb-202 exhibits long-lasting antitumor efficacy in TNBC PDx models
    Furuuchi, Keiji
    Rybinski, Katherine
    Fulmer, James
    Moriyama, Tomoyuki
    Drozdowski, Brian
    Soto, Allis
    Fernando, Shawn
    Wilson, Kerrianne
    Milinichik, Andrew
    Dula, Mary Lou
    Tanaka, Keigo
    Cheng, Xin
    Albone, Earl
    Uenaka, Toshimitsu
    CANCER SCIENCE, 2021, 112 (06) : 2467 - 2480
  • [39] Bystander activity and in vivo efficacy of a folate receptor α (FRα)-targeting antibody-drug conjugate with a novel peptide linker
    Qiu, Qifeng
    Wu, Rui
    Lanieri, Leanne
    Maloney, Erin
    Skaletskaya, Anna
    Jin, Shan
    Wang, Lintao
    Ab, Olga
    Ponte, Joe
    Setiady, Yulius
    Widdison, Wayne
    Keating, Thomas
    Chari, Ravi
    Gregory, Richard
    Hong, Erica
    CANCER RESEARCH, 2017, 77
  • [40] YH013, a novel EGFR x MET bispecific antibody-drug conjugate, exhibits potent antitumor efficacy
    Han, Yanfei
    Shang, Chengzhang
    Li, Zhuon
    Han, Zhenyan
    Li, Jun
    Cui, Zixu
    An, Gao
    Hao, Wanjun
    Liu, Yujie
    Li, Hao
    Liu, Baihong
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    Shen, Yuelei
    CANCER RESEARCH, 2023, 83 (07)
12345